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Abstract
Collagen XVI belongs to the family of fibril-associated collagens with interrupted triple helices (FACIT). It is overexpressed
during the progression of oral squamous cell carcinoma (OSCC). The present data show a strong collagen XVI-dependent
induction of MMP9 and an increase in OSCC cell invasion. We found activated integrin-linked kinase (ILK) in a complex with
kindlin-1 and activation of protein kinase B (PKB/Akt) to be responsible for MMP9 induction. Inhibition of the formation of
focal adhesions reduced MMP9 expression. Moreover, collagen XVI overexpressing OSCC cell clones (COLXVI cell clones)
transfected with vectors containing different MMP9 promoter fragments adjacent to a luciferase reporter revealed an
increase in luciferase signal dependent on AP-1 binding sites. Deletion of the AP-1 binding site 98 bp upstream of the
reported transcription start site and inhibition of AP-1 with Tanshinone IIA resulted in decreased MMP9 expression. The AP-1
subunit JunB showed differential expression between COLXVI cell clones and mock control cells. Additionally, mass
spectrometric analysis of immunoprecipitates revealed that c-Fos interacted strongly with dyskerin in COLXVI cell clones
compared to mock controls.
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Introduction
Oral squamous cell carcinoma (OSCC) is by far the most
common form of head and neck cancer [1]. Its incidence has
increased sharply over the last 10 years. Despite continued
improvements in surgery, chemotherapy and radiation therapy,
the 5-year survival rate is still only about 50% [2]. This is due to
the fact that malignant oral keratinocytes show a fast invasion of
cervical lymph nodes and spread quickly to distant sites [3]. Our
understanding of the molecular factors responsible for the strong
invasive, migratory and proliferative activity of OSCC cells is still
incomplete. Here, we present data that imply a critical role of
collagen XVI in OSCC invasion.
Collagen scaffolds in tumors are severely altered due to an
imbalanced expression of critical extracellular matrix (ECM)
components, thereby promoting cancer as they affect metabolic
activity and cell signalling [4–6]. Collagen XVI is a FACIT
collagen (fibril associated collagen with interrupted triple helices).
In normal skin, collagen XVI is incorporated into structurally and
functionally discrete matrix aggregates that are localized in the
dermal-epidermal junction zone of the papillary dermis [7,8].
Collagen XVI plays an active role in anchoring microfibrils to
basement membranes. It is not only produced by dermal
fibroblasts but also by smooth muscle cells [9], dermal dendrocytes
[10], articular and costal chondrocytes [7], endometrial stromal
cells [11], basal dermal and oral keratinocytes [8,12,15], neurons
from the dorsal root ganglion [13] and glioblastoma / astrocytoma
cells [14]. Recent studies have shown, that collagen XVI is
implicated in the development of glioblastoma and OSCC, in
which it is overexpressed during tumor progression and influences
cell cycle progression [12,14–16].
Here, we show the collagen XVI dose-dependent induction of
MMP9 in OSCC via integrin-linked kinase (ILK) and protein
kinase B (PKB/Akt). In the presence of excess collagen XVI, both
kinases were strongly activated and led to an induction of MMP9
promoter activity. We found the AP-1 binding site at 98 bp
upstream of the start codon of MMP9 to be responsible for the
induction. Closer analysis revealed that collagen XVI modulates c-
Fos/JunB expression and protein interaction partners via the
integrin/ILK/PKB/Akt signalling axis eventually leading to
enhanced MMP9 expression and invasion of OSCC cells.
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Results
Induction of full-length collagen XVI expression in an
OSCC cell line
The OSCC cell line PCI13, which is essentially devoid of
endogenous collagen XVI expression, was stably transfected with
the coding DNA sequence of full-length collagen XVI. We
generated four collagen XVI overexpressing cell clones (COLXVI
cell clones) and two mock control clones (empty vector only). The
COLXVI cell clones showed different levels of expression and
secretion of full-length collagen XVI, while the mock control cells
did not express collagen XVI (figure 1A). In COLXVI cell clones
we observed additional truncated forms of collagen XVI. We
observed an 80 kDa form, which has been described previously by
Kassner et al. [17]. In addition, we found processed bands of
collagen XVI with molecular weights of 60 kDa and 40 kDa, as
well as a band with the size of the NC11 domain of collagen XVI
(30–35 kDa, confirmed by mass spectrometry (unpublished data))
(figure 1A). To reveal potential dose-dependent effects of collagen
XVI, the collagen XVI low and high expressing clones 1 and 3
were chosen for further experiments.
Collagen XVI induces MMP-9 expression
Quantitative RT-PCR revealed an eight-fold induction of
MMP9 expression in COLXVI cell clones compared to mock
controls (figure 1B). Treating COLXVI and control cells with
additional (1 mg/mL) recombinant collagen XVI augmented the
already strong increase in MMP9 expression (figure 1B). These
data were confirmed by gelatin zymography experiments showing
strongly increased MMP9 secretion in COLXVI cell clones (figure
1C). We also observed an about 2-fold increase of MMP1 and
MMP2 gene expression in COLXVI cell clones (data not shown).
Collagen XVI overexpression leads to activation of ILK
In a previous publication we have shown that collagen XVI
exerts its effects via activation of beta1 integrin and kindlin-1 [12].
As it is known that the activation signal from integrin beta1 is
transmitted intracellularly via integrin-linked kinase (ILK) [18], we
tested if ILK was activated by phosphorylation in COLXVI cell
clones. Indeed, immunoblots showed markedly higher ILK
phosphorylation in the COLXVI cell clones than in the mock
control cells (figure 1D). To verify that ILK is responsible for
MMP9 induction, the protein was inhibited with the potent ILK
inhibitor Cpd 22. Quantitative RT-PCR revealed that inhibition
of ILK led to a 60%–80% decrease in MMP9 expression (figure
1E). In addition, gelatine zymography of cell supernatants showed
a strong decrease in MMP9 secretion into the cell culture
supernatant (figure 1F). A luciferase activity assay, which was
performed with a vector containing a 930-bp promoter fragment
cloned adjacent to a luciferase reporter, also resulted in a ,40%
decrease in MMP9 promoter activity after inhibition of ILK
(figure 1G).
Collagen XVI overexpression leads to activation of PKB/
Akt
It is known that PKB/Akt is activated downstream of ILK.
Therefore, we analyzed whether collagen XVI overexpression
activated PKB/Akt. Figure 1H shows a profound increase of
PKB/Akt phosphorylation in COLXVI cell clones compared to
mock control cells. Our observation of higher PKB/Akt
phosphorylation in COLXVI cell clones compared to mock
controls is compliant to activation of ILK.
Collagen XVI overexpression leads to an increase of ILK/
kindlin-1 interaction
Kindlin-1 is overexpressed in COLXVI cell clones [12].
Therefore, we tested if kindlin-1 interacts with ILK in our model.
The proximity ligation assay shows a clear interaction of ILK with
kindlin-1 in all observed COLXVI cell clones. Figure 2A (panel 1)
depicts the interactions of the COLXVI cell clone with the highest
collagen XVI expression. In mock control cells, there was only
very weak or no ILK/kindlin-1 interaction. Figure 2B shows the
quantification of ILK/kindlin-1 interaction as described in
Materials and Methods. COLXVI cell clones show on average
2.5 interactions per cell, whereas mock controls interact on
average 0.5 times per cell. Immunofluorescence images indicated
that ILK/kindlin-1 interactions were only observed at focal
adhesion contacts (figure 2A). This was confirmed by inhibition
of the formation of FAs with soluble arginine-glycine-aspartate
(RGD) peptides. Strikingly, quantification of the proximity ligation
assay in figure 2C revealed a significant decrease in ILK/kindlin-1
interaction in COLXVI cell clones (p,0.01) treated with 100 mg/
mL soluble RGD peptides. These data suggest that collagen XVI
induces ILK/kindlin-1 interaction. Further, decrease in MMP9
gene expression was found to be dependent on the amount of
soluble RGD-peptides employed to inhibit focal adhesions (figure
2D). The co-immunoprecipitation experiment with kindlin-1 and
ILK in figure 2E corroborates our findings. There were similar
levels of ILK expression in low and high expressing COLXVI
clones and mock controls. However, immunodetection of kindlin-1
in these precipitates revealed a collagen XVI dose dependent
ILK/kindlin-1 interaction with mock controls showing least
interaction.
The AP-1 binding site at –98bp is important for collagen
XVI dependent MMP9 induction
To identify the promoter region of MMP9 responsible for
collagen XVI-dependent induction, we cloned MMP9 promoter
fragments (90 bp, 530 bp and 930 bp upstream of the MMP9 start
codon, respectively) adjacent to a luciferase reporter gene. The
930-bp promoter region contained two AP-1 binding sites, the
530-bp region a single AP-1 site, while the 90-bp region contained
no AP-1 binding site (figure 3A). These constructs were each
transfected into our COLXVI and mock cell clones. Compared to
the COLXVI low expressing and the mock control cell clones,
MMP9 promoter activity of the 930-bp and 530-bp regions was
twice as high in the COLXVI high expressing cell clone. In
addition, the two longer promoter fragments revealed higher
luminescence intensity than the 90-bp fragment (figure 3B).
Since the two longer promoter fragments exhibited higher
reporter activity than the 90-bp fragment containing no AP-1
binding site, we concluded that AP-1 was involved in MMP9
induction.
The additional AP-1 site in the 930-bp fragment did not cause a
further increase in luciferase reporter signal over that of the 530-
bp fragment containing only the AP-1 site at –98bp. Therefore, we
hypothesized that the latter was solely responsible for MMP9
induction (figure 3B). To test this assumption we deleted the AP-1
binding site in the 530 bp fragment (figure 3C). This led to a 4-fold
decrease in luciferase activity, thus confirming that the AP-1 site at
-98 bp was indeed responsible for MMP9 induction (figure 3D).
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COLXVI cell clones show an interaction of c-Fos and
dyskerin together with an increased nuclear JunB
localization
We performed RT-PCR experiments to screen for the most
abundantly expressed AP-1 protein isoforms in our cell lines.
Among all tested AP-1 family members (FOS, JUNB, JUND;
FRA1, FRA2), FOS and JUNB showed robust expression levels.
Expression of c-Fos has been reported to be associated with
MMP9 expression [19]. Since our data implied involvement of
AP-1 in collagen XVI-induced MMP9 expression, we compared
the c-Fos protein expression in COLXVI cell clones with mock
control cells. Analysis of nuclear extracts did not show any
differences in c-Fos expression between COLXVI cell clones and
mock controls (figure 4A first row). Immuno-fluorescence analysis
also failed to reveal any difference in the nuclear amount of c-Fos
expression in COLXVI cell clones compared to mock controls
(figure 4B, images). Semiquantitative evaluation confirmed these
data (figure 4B). Next we searched for interaction partners of c-Fos
in COLXVI cells vs mock controls. To that end, we performed an
immunoprecipitation experiment with subsequent reducing SDS-
PAGE electrophoresis of the immunoprecipitate. A protein band
with a molecular weight of 58 kDa distinguished COLXVI cells
Figure 1. COLXVI overexpression induces MMP9 expression. (A) Immunoblot analysis of collagen XVI secretion in supernatants of COLXVI
cell clones (clones 1-4) and mock control cells (mock 1-2). Only COLXVI cell clones secret the full-length form of COLXVI (213 kDa; black arrow). Clones
3 and 4 exhibit higher COLXVI secretion than clones 1 and 2. COLXVI cell clones also secrete collagen XVI fragments. A Coomassie Blue membrane
staining was used as loading control. (B) Quantitative PCR of MMP9 expression in COLXVI cell clones and mocks after 24 h incubation with/without
recombinant collagen XVI. COLXVI cell clones (1-4) show a significant expression of MMP9 that is further enhanced by the addition of recombinant
collagen XVI (n = 3). (C) Gelatin zymography of COLXVI cell supernatant and mock controls. The COLXVI cell clones (1-4) show a clear gelatinolytic
activity at 92 kDa (pro form). In contrast, the mock control cells (1-2) show very weak MMP9 bands. (D) Immunoblot of total ILK and phosphorylated
ILK (P ILK) isolated from membrane fractions of COLXVI cell clones and mock control cells. ILK is activated in COLXVI cell clones whereas in mock
control cells P-ILK is lacking. (E) Quantitative PCR of MMP9 expression after ILK inhibition with Cpd 22 (ILKi). The expression of MMP9 decreased after
ILK inhibition in the COLXVI cell clones. (n = 3). (F) Gelatin zymography of the supernatant of the COLXVI cell clone 3 after ILK inhibition with Cpd 22
(ILKi; c = 300nM). After ILK inhibition the COLXVI cell clone depicts decreased MMP9 secretion. (G) Promoter activity of the COLXVI cell clone 3 after
ILK inhibition with Cpd 22 (ILKi; c = 300 nM). ILK inhibition results in a significant decrease of the MMP9b promoter activity. (p,0.001; n = 3). (H)
Immunoblot of total Akt/PKB and phosphorylated Akt/PKB (P-Akt/PKB) in cell lysates of COLXVI cell clones (clones 1-4) and mock control cells (1-2).
Akt/PKB activation is increased in COLXVI cell clones compared to mock controls.
doi:10.1371/journal.pone.0086777.g001
Collagen XVI Induces Invasion via MMP9
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e86777
from control cells (figure 4C). Tandem mass spectrometry of a
tryptic digest of this band revealed the protein dyskerin as being
the differential interaction partner of c-Fos in COLXVI cells. In
comparison, control cells showed only a very faint interaction of c-
Fos with dyskerin. Co-immunoprecipitation experiments con-
firmed these findings (figure 4D) indicating an increased c-Fos/
dyskerin interaction in COLXVI clones in contrast to mock
control cells. Immunoblot analyses and immunofluorescence
Figure 2. Collagen XVI overexpression leads to an increase of ILK/kindlin-1 interaction. (A) Proximity ligation assay for the analysis of ILK/
kindlin-1 interaction in COLXVI and mock control cells (scale bar equals 50 mm). COLXVI cell clones exhibit an increased interaction of kindlin-1 and
ILK at focal adhesions compared to mock control cells (A+B). After inhibition of focal adhesion formation with soluble RGD peptides (c = 100 mg/mL)
ILK/kindlin-1 interaction was significantly reduced (p,0.001, n = 100) (A+C). (D) Quantitative PCR of MMP9 gene expression in COLXVI cell clones and
mocks after 24 h incubation with soluble RGD peptides. Inhibition of focal adhesions via soluble RGD-peptides resulted in a dose-dependent
decrease in MMP9 gene expression (n = 3). (E) Co-Immunoprecipitation of ILK and kindlin-1 of protein extracts isolated from COLXVI clones and
mocks. COLXVI cell clones exhibit an increased ILK/kindlin-1 interaction depending on collagen XVI dose. Mock control cells showed least ILK/kindlin-
1 interaction.
doi:10.1371/journal.pone.0086777.g002
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staining corroborated these data, showing increased nuclear
dyskerin expression in COLXVI cells compared to mock control
cells (figure 4 E and F).
Western blot analysis of JunB protein expression revealed a
clear upregulation in nuclear JunB expression in COLXVI cells
(figure 4A, second row). We had not observed an upregulation of
JUNB at the mRNA level (data not shown). Immunofluorescence
staining of COLXVI cells and control cells confirmed the
significant increase in nuclear JunB protein expression in
COLXVI cells compared to mock controls (figure 4G). These
data suggest a clear difference in AP-1 protein distribution and
protein interaction in COLXVI cells compared to mock control
cells.
Inhibition of AP-1 leads to downregulation of MMP9
expression
To test whether AP-1 participates in the regulation of collagen
XVI-dependent MMP9 gene expression we inhibited AP-1 with
Tanshinone IIA. A significant decrease in MMP9 gene expression
was observed in COLXVI cells. We did not observe a significant
change in MMP9 gene expression in mock control cells after
inhibition with Tanshinone IIA (figure 5 A).
Collagen XVI overexpression leads to an increased
invasion of OSCC cells
To analyze if collagen XVI-induced MMP9 expression leads to
OSCC cell invasion, we generated 3D micromass pellets of
COLXVI cells and mock controls and embedded them in partially
degraded collagen I gel. After 48 h, COLXVI cells yielded a
significantly larger invasion zone compared to the mock controls
(figure 5B). The cores of the COLXVI cell 3D micromass pellets
were more diffuse than those of the mock control cells and the
invasion zones were significantly wider. Moreover, we observed a
sheet like invasion pattern of COLXVI cells, while mock controls
exhibited a rather diffuse cellular invasion pattern (figure 5B).
To ascertain that exogenous treatment of OSCC cells with
excess of recombinant collagen XVI also resulted in an increased
invasion we added recombinant collagen XVI at a concentration
of 500 ng/mL during the generation of mock control micromass
pellets. Again, the areas of the invaded spheroids in partially
degraded collagen I matrix were determined after 48 h.
Interestingly, in COLXVI cell clones we observed a profoundly
higher invasion in the partially degraded collagen I matrix
compared to mock control cells without exogenous collagen XVI
(figure 5C)
Figure 3. The AP-1 binding site at –98bp is important for collagen XVI dependent MMP9 induction. (A) Schematic presentation of the
three different MMP9 promoter fragments. MMP9a, MMP9b, and MMP9c contain 0, 1, and 2 AP-1 binding sites, respectively. (B) Comparison of MMP9
promoter activities of MMP9a, MMP9b, and MMP9c in COLXVI and control cells, respectively. The shortest MMP9 promoter fragment (MMP9a)
exhibits the lowest activation. In general, COLXVI clones reveal a higher activation of the MMP9 promoter than the mock control cells. The luciferase
reporter shows increased activation of the MMP9 promoter in clone high compared to clone low (n= 3). (C) Schematic presentation of the MMP9b
promoter and the MMP9b deletion promoter, respectively. The MMP9b deletion promoter does not contain the AP-1 binding site 98 bp upstream
from the start codon. (D) Promoter activity of the MMP9b promoter after deletion of the AP-1 binding site. After deletion of the AP-1 binding site the
MMP9b promoter activity decreases significantly (n = 3).
doi:10.1371/journal.pone.0086777.g003
Collagen XVI Induces Invasion via MMP9
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e86777
Discussion
In normal oral epithelium as in the dermis, collagen XVI is
predominantly located at the dermal-epidermal junction [8,16].
Collagen XVI is involved in dermal architecture by interacting
with integrins alpha1beta1, alpha2beta1 and the microfibrillar
apparatus [8,20]. Collagen XVI also plays a role in tumorigenesis.
It was demonstrated, that collagen XVI expression is up-regulated
in glioblastoma [14] and its inhibition leads to reduced glioma
invasiveness [16]. Dysplastic stages of OSCC exhibit an excessive
amount of collagen XVI [12]. Our group has shown that collagen
XVI overexpression in OSCC facilitates early S-phase entry [12].
The present data suggest in addition, that collagen XVI induces
MMP9 expression via the specific AP-1 promoter region located
98 bp upstream of the start codon of MMP9. We noticed a
concurrence between the amount of collagen XVI protein
expression and MMP9 promoter induction, as the cell clones with
most abundant collagen XVI expression tended to induce the
MMP9 promoter stronger than cell clones with less collagen XVI
expression. We detected a strong gelatinolytic activity at 88 kDa
and 92 kDa in oral squamous cell carcinoma cells treated with a
high concentration of recombinant collagen XVI. These bands
correspond to the activated and pro (latent) forms of MMP9,
respectively. Increased expression of MMP9 has been associated
with the acquisition of an invasive phenotype in many tumors.
MMP9 is activated early during melanoma progression and is
secreted by keratinocytes [21]. In tongue squamous cell carcinoma
high MMP9 expression is observed in neoplastic cells at the
invasion front [22]. In OSCC, MMP9 serves as a predictor of
tumor recurrence when detected in histologically-negative surgical
margins of OSCC [23]. Moreover, a direct link was shown by a
strong reduction of invasion and adhesion of ovarian cancer cells
after treatment with MMP-9 siRNA [24]. Furthermore, oral
squamous cell carcinoma cells exhibited reduced invasion after
suppression of MMP9 via ESE-1 [25] and Heikkila¨ et al. illustrated
that selective antigelatinolytic peptides specifically designed against
MMP2 and MMP9 clearly inhibited invasion of tongue squamous
cell carcinoma cells [26]. Moreover, we observed a differential
upregulation of the AP-1 family members JunB and c-Fos in
COLXVI cells compared to mock control cells. AP-1 family
members have been implicated in oral carcinogenesis [27]. Mishra
et al. could show that precancerous cases exhibit JunD homodi-
mers, whereas c-Fos/JunD was the most prevalent complex found
in cancer tissues. Further, c-Fos showed a specific interaction with
dyskerin (DKC1), an important component of the telomerase
complex in OSCC cells. This interaction has not yet been
Figure 4. Collagen XVI overexpression leads to c-Fos – dyskerin interaction and increased nuclear JunB localization. (A) Immunoblot
analyses of JunB and c-Fos nuclear extracts from COLXVI cell clones and mock control cells. COLXVI cell clones show a higher amount of JunB
compared to mock control cells. COLXVI cell clones do not differ from mock control cells in c-Fos expression. (B) Immunofluorescence staining of c-
Fos (green) in COLXVI cell clones and mock control cells (scale bar equals 50 mm). COLXVI cell clones do not differ from mock control cells in their c-
Fos expression. Quantification was performed measuring the fluorescent intensity of 100 COLXVI cells and mock controls, each. (C) Silver stained gel
of protein lysates from COLXVI cell clones and mock control cells, respectively, after immune precipitation of c-Fos. In COLXVI cell clones a band with
a size of 58 kDa was differentially expressed. Mass spectrometry revealed it as dyskerin. (D) Co-immunoprecipitation of c-Fos and dyskerin of protein
extracts isolated from COLXVI clones and mocks. COLXVI cell clones exhibit an increased interaction of c-Fos and dyskerin compared to mock control
cells. (E) Dyskerin immunoblot of nuclear extracts from COLXVI cell clones and mock control cells. COLXVI cell clones exhibit a higher protein amount
of dyskerin than mock control cells. (F) Immunofluorescence staining of dyskerin (red) in COLXVI cell clones and mock control cells (scale bar equals
50 mm). COLXVI cell clones showed strong dyskerin staining compared to mock control cells (G). Immunofluorescence staining of JunB (red) in
COLXVI clones and mock control cells (scale bar equals 50 mm). COLXVI cell clones exhibit stronger JunB staining compared to mock control cells.
Quantification of signal intensity demonstrates significantly increased nuclear JunB expression in COLXVI cells compared to mock controls.
doi:10.1371/journal.pone.0086777.g004
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described in the literature but Sachdev et al. found a gradual
increase of c-Fos expression in the oral cavity from normal oral
mucosa to premalignant lesions to squamous cell carcinoma [28].
Moreover, comparing different stages of oral carcinogenesis in 100
oral tissue specimen Mishra et al. described a constitutive
activation of AP-1 and a concomitant upregulated expression of
the majority of AP-1 family of proteins and mRNA [27].
Overexpression of dyskerin has been detected in oral squamous
cell carcinoma and in immortalized and transformed keratinocytes
[29]. In accordance with Alawi et al., upregulation of dyskerin
correlates with increased cell proliferation rate and tumor growth
[29].
As for JunB, Wang et al. demonstrated that the expression level
of JunB significantly increased in human colorectal adenocarci-
nomas [30]. Furthermore, the expression of JunB is enhanced in 4-
nitroquinoline 1-oxide induced rat tongue cancers [31]. These
data fit well with the upregulation of JunB in our COLXVI cells
and underline the supporting role of collagen XVI during the
progression of OSCC. Furthermore, we have observed a strong
activation of ILK and PKB/Akt in COLXVI cells. Inhibition of
ILK led to the downregulation of MMP9 protein expression and
secretion, suggesting a direct link between ILK-signaling and
MMP9 expression. Inhibition of ILK also led to a strong reduction
of MMP2 expression and activity, suggesting the existence of a
general ILK-dependent mechanism underlying MMP regulation.
Toussard et al. have shown, that ILK overexpression in intestinal
and mammary epithelia cells results in an upregulation of MMP9
secretion and therefore in a highly invasive phenotype. Inhibition
of ILK leads to a decreased activation of AP-1 and deceased
MMP9 promoter activity [32]. This is consistent with our data.
Figure 5. Collagen XVI overexpression leads to increased invasion of OSCC cells. (A) Quantitative PCR of MMP9 gene expression of COLXVI
and mock control cells after AP-1 inhibition with Tanshinone IIA (TIIA; c = 100 ng/mL). The expression of MMP9 decreased in the COLXVI cell clones
after AP-1 inhibition with Tanshinone IIA. (n = 3) (B) 3D micromass pellets of COLXVI cells compared to mock control cells 24 h after placement.
COLXVI cells (high and low expressing) show a significantly wider invasion zone (orange line) compared to mock control cells (p,0.01; n = 10). (C) 3D
micromass pellets of mock control cells after 24 h of incubation with 500 ng/mL recombinant collagen XVI. Incubation with recombinant collagen XVI
resulted in a significantly increased spreading of the invasion zone (orange line) compared to the control (p,0.001; n = 10).
doi:10.1371/journal.pone.0086777.g005
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Increased ILK expression correlates strongly with OSCC tumor
invasion, higher tumor grade, advanced clinical stage, positive
lymph node status and increased risk of recurrence [33].
Moreover, PKB/Akt activation contributes to a worse outcome
in patients with tongue cancer [34]. Our previous data showed an
upregulation of kindlin-1 in COLXVI cells [12]. Kindlin-1 has
been observed to regulate polarity, proliferation and motility in
epidermal keratinocytes, and it is required for RhoGTPase-
mediated lamellipodia formation in keratinocytes [35]. Here, we
demonstrated that COLXVI cells exhibited a significant amount
of ILK/kindlin-1 interaction compared to the control cells at focal
adhesion (FA) contacts. Blocking FAs via soluble RGD peptides
[36] led to a significant decrease of ILK/kindlin-1 interaction and
caused a downregulation of MMP9 gene expression, suggesting
that this interaction plays a critical role in AP-1 induced MMP9
induction. We have already found putative integrin binding
domains for collagen XVI [20]. These domains do not contain
RGD sequences. Therefore, it is unlikely that the observed effect
of diminishing ILK/kindlin-1 interaction is due to a displacement
of collagen XVI by soluble RGD peptides. Montanez et al.
revealed an interaction between Kindlin-2 and ILK in mouse
fibroblasts and proposed that Kindlin-2 is required for ILK
localization in FAs [37]. In summary, our study demonstrates a
strong impact of abundant collagen XVI expression on the
induction of MMP9 in OSCC cells. This induction occurs via
increased phosphorylation of ILK and PKB/AKT together with
enhanced ILK/kindlin-1 interaction. Additionally, collagen XVI
leads to an alteration of interaction partners and expression of AP-
1 proteins. This makes collagen XVI a possible molecular target
for optimized future cancer therapies and even a suitable
diagnostic tool.
Materials and Methods
Cell lines and culture conditions
The human OSCC cell line PCI13 was kindly provided by Prof.
T.L.Whiteside (University of Pittsburgh Cancer Institute (PCI),
Pittsburgh, PA). The cell line was established from primary tumors
in the laboratory at the University of Pittsburgh as described
previously [38]. The PCI13 cell line was established from a male
patient, who suffered from low-grade OSCC of the retromolar
triangle. The tumour stage was pT4pN1M0G3. The cells were
maintained in DMEM containing 10% FCS (Invitrogen, Darm-
stadt, Germany), 2 mmol/L L-glutamine (PAA, Coelbe, Ger-
many), and 1% penicillin/streptomycin (Sigma, Steinheim,
Germany). Inhibition of ILK was performed with the ILK-
Inhibitor Cpd 22 (Millipore, Billerica, USA, dissolved in DMSO
(Sigma), stock concentration: 10 mM; concentration for inhibition:
300 nM). Inhibition of focal adhesion formation was performed
with RGD-Peptides (Abbiotec, USA, dissolved in DMEM
medium, stock concentration: 2 mg/ml). AP-1 was inhibited with
Tanshinone II A (Torcis, UK, dissolved in DMSO (Sigma), stock
concentration: 1 mg/ml; concentration for inhibition: 100 ng/ml)
Cloning
For transfection experiments, PCI13 cells were transfected with
the expression vector pCEP-Pu BM40SP C-StrepII [17,38] using
FuGene HD Transfection Reagent (Roche, Penzberg, Germany)
to stably express recombinant collagen XVI. The cell clones were
denominated COLXVI C1-4. The coding sequence was inserted
between restriction sites NheI and NotI. Growth medium for
transfected cells was DMEM, 10% FCS (Pan) supplemented with
0.25 mg/mL puromycin (Biomol, Hamburg, Germany). Stable
mock control cell lines were transfected with pCEP-Pu BM40SP
vector without the collagen XVI coding sequence. The mock
controls were denominated mock1 and mock2. Recombinant
collagen XVI was purified from culture medium by means of one-
step gravity flow affinity chromatography using Strep-Tactin
Superflow (IBA, Go¨ttingen, Germany) columns as described in
Kassner et al. [17].
Immunoblot analysis
Lysates were prepared using RIPA buffer (Sigma) containing
protease inhibitor (Roche). The protein concentration of the cell
lysates was determined by bicinchoninic acid assay (BCA, Pierce,
Rockford, IL), stored at –20uC. 30 mg of total protein were
separated by SDS-PAGE using a 10% resolving gel and
transferred onto PVDF membrane. Blots were blocked in 3%
BSA (Sigma) in PBS (Sigma) containing 0.1% Tween 20 (Sigma).
Primary antibodies (with the exception of collagen XVI all from
Santa Cruz, Dallas, TX): collagen XVI (1:5,000, Sigma), ILK
(1:200), P-ILK (1:200), c-Fos (1:200), P-c-Fos (1:200), Akt/PKB
(1:200), and P-Akt/PKB (1:200). All appropriate secondary
antibodies conjugated with horseradish peroxidase were purchased
from Pierce. For protein visualization Roti Lumin kit (Roth,
Karlsruhe, Germany) was used. Equal loading was verified with
mouse antibody against beta-actin (1:10,000, Abcam, Cambridge,
UK). Semiquantitative analysis in figure 4 was performed by
referring the band intensity to Histone H3. All experiments were
repeated at least 3 times.
Co-immunoprecipitation
Lysates were prepared using RIPA buffer (Sigma) containing
protease inhibitor (Roche). The protein concentration of the cell
lysates was determined by bicinchoninic acid assay (BCA, Pierce,
Rockford, IL), stored at –20uC. 200 mg of total protein were
immune precipitated by mMACSTM Protein A/G MicroBeads
MultiMACSTM Protein A/G Kit (Miltenyi Biotec, Bergisch
Gladbach, Germany) and performed according to the manufac-
turer’s instructions. The following immunoblot analyses were
performed as described above. Antibodies for immunoprecipita-
tion: ILK (4 mg per immunoprecipitation; SantaCruz), c-Fos (2 mg
per immunoprecipitation; SantaCruz). Primary antibodies: ILK
(1:200; SantaCruz), c-Fos (1:200; SantaCruz), kindlin-1 (1:500;
polyclonal rabbit; Abcam), dyskerin (1:200; SantaCruz)
Gelatine zymography
For gelatine zymography, cells were cultured for 24 h without
FCS. Supernatants were harvested and concentrated with
centrifugal filters (Amicon, Tullagreen, Ireland). Aliquots of
supernatants, containing an amount of 2 mg of total protein, were
mixed with equal volumes of two-fold concentrated sample
loading buffer (2 mM EDTA, 2% SDS, 20% glycerol, 0.02%
bromophenol blue, 20 mM Tris/HCl, pH 8.0) and subjected to
electrophoresis in 10% SDS-polyacrylamide gels containing 1%
gelatine. Subsequently, gels were washed twice for 30 min in 2.5%
Triton-X 100, rinsed in distilled water, and developed for 48 h at
37uC in 50 mM Tris/HCl, pH 8.5, containing 5 mM CaCl2.
Finally, the gels were stained with Coomassie Brilliant Blue R250
(Serva, Germany) to visualize protease activity and were photo-
graphed.
Immunocytochemistry
Cells were plated on 8 ChamberSlides (BD, Franklin Lakes, NJ)
and fixed with 4% paraformaldehyde for 10 min. Cultured cells
were washed with PBS and blocked with 3% (v/v) normal goat
serum (Sigma) in PBS for 60 min at 37uC. Appropriate first
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antibodies were diluted in 1.5% (v/v) normal goat serum (Sigma)
and incubated over night at 4uC: c-Fos (polyclonal; rabbit IgG:
2 mg/mL, Santa Cruz sc-52); JunB (monoclonal; mouse IgG1:
2 mg/mL, Santa Cruz sc-8051); dyskerin (monoclonal; mouse
IgG1: 2 mg/mL, Santa Cruz sc-365731). The secondary antibody
was diluted in 1.5% (v/v) normal goat serum (Sigma) in PBS and
incubated at 37uC for 1 h. For immunocytochemistry, secondary
antibodies linked to fluorescent dyes AlexaFluor 488 and
AlexaFluor 568 (Molecular Probes, Eugene, OR), respectively,
were used: Goat anti-rabbit AlexaFluor 488: 1:500; goat anti-
mouse AlexaFluor 568: 1:500. Nuclei were counter-stained with
300 nM DAPI (Molecular Probes) for 10 min. To quantify c-Fos
and JunB expression, the mean of grey for each cell (n = 100) was
measured using the open-source software ImageJ 1.46r [39] and
divided by the cell area.
Proximity ligation assay
Interaction of kindlin-1 and integrin-linked kinase (ILK) was
analysed by means of a proximity ligation assay (DuolinkH,
Eurogentec, Seraing, Belgium) performed according to the
manufacturer’s instructions [40]. First antibodies: ILK (polyclonal
goat; Santa Cruz), kindlin-1 (polyclonal rabbit; Abcam). An
antibody against the N-terminus of integrin beta (Millipore,
Billerica, MA) served as negative control. Secondary antibodies
were used against rabbit (plus-DNA-strand) and goat (minus-
DNA-strand), respectively. First antibodies: Appropriate first
antibodies were diluted in blocking buffer 1h at 37uC in a humid
chamber. PLA Probes: Anti-goat minus dilution 1:5. Anti-rabbit
plus dilution 1:5 incubated 1 h at 37uC in a humid chamber.
Ligation: 30 min at 37uC in a humid chamber. Amplification: 120
min at 37uC in a humid chamber. For the quantification of the
kindlin-1 – ILK interaction, interactions were counted and divided
by the cell number (n = 100) in each picture. Cells were counted in
five pictures with a magnification of 400x. Each data point
represents the average interactions per cells for one image.
RNA isolation and quantitative real-time polymerase
chain reaction
Total cellular RNA was isolated using the RNeasy mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. Reverse transcription of 1 mg RNA to complementary
DNA (cDNA) was performed using transcriptor high fidelity
cDNA synthesis kit (Roche) according to the manufacturer’s
protocol. cDNA was amplified using the Brilliant III ultra fast
quantitative polymerase chain reaction master mix (Stratagene
Agilent Technologies, Santa Clara, CA) in combination with
TaqMan UPL probes (Roche). Real-time PCR primers were
obtained from Eurofins (Ebersberg, Germany). 18S mRNA was
used for normalization. Primers: 18s: 59- GCAATTATTCCC-
CATGAACG-39 and 59-GGGACTTAATCAACGCAAGC-39,
probe #48. MMP9: 59-TTCGACGATGACGAGTTGTG-39
and 59-TCCAAACCGAGTTGGAACC-39, probe: #61. FOS:
59-GGGGCAAGGTGGAACAGT-39 and 59-
TCTCCGCTTGGAGTGTATCA-39, probe: #24. JUNB: 59-
CAAGGTGAAGACGCTCAAGG-39 and 59-TCAT-
GACCTTCTGTTTGAGCTG-39, probe #32.
Luciferase activity assay
Linked to the luciferase gene, the different promoter fragments
of MMP9 were cloned in the pGL4.16 (luc2/Neo) vector
(Promega, Fitchburg, WI) according to the manufacturer’s
instructions. The control vector was pGL4.74 (hRluc/TK)
(Promega). The COLXVI cells were transiently transfected with
FuGene HD Transfection Reagent (Roche) with the described
vectors. The luciferase activity was measured using the Dual-
LuciferaseH Reporter Assay System (Promega) according to the
manufacturers instructions. To design the cloning promoters the
sequence of the MMP9 transcript ENST00000372330 from
Ensembl.org (accessed 2013 Dec 20) was used. Promoter primers:
90-bp promoter: 59-TACATTTACATTGGTACCAG-
CACTTGCCTGTCAAGGA-39 and 59- TTGATACTCGAGC-
CAGCACCAGGAGCACC-39; 530-bp promoter: 59-TA-
CATTGGTACCAAAGAGGACAGAGCCTGGA-39 and 59-
TTGATACTCGAGCCAGCACCAGGAGCACC-39; 930-bp
promoter: 5-‘tacattGGTACCTCTTGGGTCTTGGCCT-
TAGT-39 and 59- TTGATACTCGAGCCAGCACCAGGAG-
CACC-39.
Invasion Assay
For invasion measurements 3D micromass pellets were gener-
ated. For each 3D micromass pellet, 400 cells were seeded for 24 h
in cone-shaped 96-well plates (Nunc, Germany). The 3D
micromass pellets were then placed in degenerated Collagen I
matrix (PureCol, Advanced BioMatrix, San Diego, CA; 1 mg/
mL, pH 7.5) and cultured for 48 h. The 3D micropelletes were
photographed before and 48h after cultivation in degenerated
Collagen I matrix. The area of the invasion zone was measured
using Photoshop CS4.
Liquid chromatography-tandem mass spectrometry
COLXVI cells and mock control cells were synchronized and
subsequently cultured in DMEM medium (10% FCS, 1%
Penicillin/Streptavidin, 2 mmol/L L-Glutamin) for 24 h. After-
wards, cell lysates were prepared using RIPA buffer. 200 mg of
total protein were immunoprecipitated according to the manu-
facturer’s instructions (Miltenyi Biotec; mMACSTM Protein A/G
MicroBeads) with the appropriate antibody. The precipitates were
separated by SDS-PAGE. Gels were stained with EZ blue gel
staining reagent (Sigma-Aldrich) for 16 h at room temperature.
Afterwards, respective bands were excised and gel pieces were
washed three times alternately with 50 mL 50 mM NH4HCO3
and 25 mM NH4HCO3 in 50% acetonitrile (Merck, Darmstadt,
Germany). Subsequently, the gel slices were dried in a vacuum
centrifuge. 5 mL of trypsin solution (Promega, Mannheim,
Germany) (12.5 ng/mL in 50 mM ammoniumbicarbonate (Ap-
pliChem, Darmstadt, Germany)) were added to each gel piece and
incubated at 37uC overnight for in-gel-digestion. The obtained
peptides were eluted with 20 mL of 5% formic acid (Merck) and
subjected to nano-LC-MS/MS-analysis. Nano-LC was performed
on an Ultimate 3000 nano-HPLC-system (Dionex GmbH, Idstein,
Germany). Samples were pre-concentrated on a 2 cm x 100 mm
I.D. C18-column (nanoseparations, Nieuwkoop, The Netherlands)
using 0.1% trifluoroacetic acid (Merck) at a flow-rate of 8 mL/min.
The peptides were then separated on a 15 cm675 mm I.D. C18-
PepMap-column (flow-rate 300 mL/min; Dionex GmbH, Idstein,
Germany) using a 1 h binary gradient from 5-50% solvent B
(solvent A: 0.1% formic acid; solvent B: 0.1% formic acid/84%
acetonitrile). The nano-HPLC was coupled directly to a QTOF
mass spectrometer (QStar XL, AB Sciex, Darmstadt, Germany)
acquiring repeatedly one full-MS and two tandem-MS-spectra of
the most intensive ions in the respective full MS-scan. The
tandem-MS-spectra were searched against the Uniprot-database
using the Mascot Daemon and the Mascot algorithm (version 2.1;
Matrix Science Ltd., London, UK) with the following adjustments:
taxonomy: Homo sapiens, trypsin as protease, max. one missed
cleavage site, oxidation of methionine, pGlu for N-terminal Gln as
variable modifications, 0.2 Da-tolerance for MS and MS/MS-
Collagen XVI Induces Invasion via MMP9
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e86777
signals, only doubly and triply charged ions. Only proteins, for
which at least two different peptides could be identified in
significantly scored spectra after manual verification, were
considered.
Statistical analysis
Significances were determined with assistance of GraphPadPr-
ism V.6 using Mann Whitney U test. P,0.05 was considered as
significant. Error bars represent standard deviation.
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